99 related articles for article (PubMed ID: 11418894)
1. Osteonecrosis in human immunodeficiency virus-infected patients may not be related to immune reconstitution.
Skiest DJ
Clin Infect Dis; 2001 Jul; 33(2):268-70. PubMed ID: 11418894
[No Abstract] [Full Text] [Related]
2. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus.
Monier P; McKown K; Bronze MS
Clin Infect Dis; 2000 Dec; 31(6):1488-92. PubMed ID: 11096017
[TBL] [Abstract][Full Text] [Related]
3. Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children.
van Rossum AM; de Groot R
Pediatr Infect Dis J; 2003 Oct; 22(10):934; author reply 934-5. PubMed ID: 14551497
[No Abstract] [Full Text] [Related]
4. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
5. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.
Weinberg A; Wiznia AA; LaFleur BJ; Shah S; Levin MJ
J Infect Dis; 2004 Jul; 190(2):267-70. PubMed ID: 15216460
[TBL] [Abstract][Full Text] [Related]
6. Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following interruption of highly active anti-retroviral therapy.
Soriano-Sarabia N; Abad MA; Vallejo A; Gutiérrez S; Leal M
Clin Microbiol Infect; 2006 Mar; 12(3):290-3. PubMed ID: 16451419
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: Is there a real connection? The first case-control study.
de Larrañaga G; Bottaro E; Martinuzzo M; Figueroa R; Iglesias Varela ML; Perés Wingeyer S; Forastiero R; Adamczuk Y; Corti M; Puga L; Benetucci J
Clin Appl Thromb Hemost; 2009; 15(3):340-7. PubMed ID: 18160564
[TBL] [Abstract][Full Text] [Related]
8. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
9. Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy.
Simonelli C; Tedeschi R; Gloghini A; Bortolin MT; Spina M; Bidoli E; Cinelli R; De Paoli P; Carbone A; Tirelli U
Clin Infect Dis; 2005 Apr; 40(7):1022-7. PubMed ID: 15824995
[TBL] [Abstract][Full Text] [Related]
10. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person.
Lawn SD; Wood C; Lockwood DN
Clin Infect Dis; 2003 Jan; 36(1):e5-6. PubMed ID: 12491222
[TBL] [Abstract][Full Text] [Related]
11. Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control.
Sufka SA; Ferrari G; Gryszowka VE; Wrin T; Fiscus SA; Tomaras GD; Staats HF; Patel DD; Sempowski GD; Hellmann NS; Weinhold KJ; Hicks CB
J Infect Dis; 2003 Apr; 187(7):1027-37. PubMed ID: 12660916
[TBL] [Abstract][Full Text] [Related]
12. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
13. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
14. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.
Siddique MA; Hartman KE; Dragileva E; Dondero M; Gebretsadik T; Shintani A; Peiperl L; Valentine F; Kalams SA
J Infect Dis; 2006 Sep; 194(5):661-5. PubMed ID: 16897665
[TBL] [Abstract][Full Text] [Related]
15. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy.
Dufour V; Wislez M; Bergot E; Mayaud C; Cadranel J
Clin Infect Dis; 2003 May; 36(10):e127-30. PubMed ID: 12746792
[TBL] [Abstract][Full Text] [Related]
16. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S
J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294
[TBL] [Abstract][Full Text] [Related]
17. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
Phillips P; Bonner S; Gataric N; Bai T; Wilcox P; Hogg R; O'Shaughnessy M; Montaner J
Clin Infect Dis; 2005 Nov; 41(10):1483-97. PubMed ID: 16231262
[TBL] [Abstract][Full Text] [Related]
18. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
19. Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response.
Kovacs A; Montepiedra G; Carey V; Pahwa S; Weinberg A; Frenkel L; Capparelli E; Mofenson L; Smith E; McIntosh K; Burchett SK;
J Infect Dis; 2005 Jul; 192(2):296-302. PubMed ID: 15962224
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy.
Molia AC; Strady C; Rouger C; Beguinot IM; Berger JL; Trenque TC
Ann Pharmacother; 2004 Dec; 38(12):2050-4. PubMed ID: 15507502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
